BACKGROUND: Previous research has indicated positive effects of early developmental intervention (EDI) on the development of children in developing countries. Few studies, however, have examined longitudinally when differential treatment effects may be observed and whether differential outcomes are associated with exposure to different risk factors and country of implementation. Also, birth asphyxia as a risk condition has not been well studied. To address these limitations, we conducted a randomized controlled trial to test the hypothesis that there will be differential developmental trajectories favoring those who receive EDI versus a health education intervention in children in rural areas of India, Pakistan, and Zambia. METHODS:Children with and without birth asphyxia were randomized to EDI or control intervention, which was implemented by parents who received training in biweekly home visits initiated before child age 1 month and continuing until 36 months. Development was assessed in 376 children at ages 12, 24, and 36 months using the Bayley Scales of Infant Development and Ages &; Stages Questionnaire administered by evaluators blind to intervention assignment and risk condition. RESULTS: Longitudinal mixed model analysis indicated that EDI resulted in better development over 36 months in cognitive abilities, regardless of risk condition, maternal resources, child gender, or country. Psychomotor development and parent-reported general development showed similar trends as for cognitive abilities, but were not statistically different between intervention conditions. Developmental differences were observed first at 36 months of age. CONCLUSION: Early developmental intervention has promise for improving development in children across developing countries when exposed to various risk conditions. EDI should be one prominent approach used to begin to address long-term outcomes and intergenerational transmission of poverty.
RCT Entities:
BACKGROUND: Previous research has indicated positive effects of early developmental intervention (EDI) on the development of children in developing countries. Few studies, however, have examined longitudinally when differential treatment effects may be observed and whether differential outcomes are associated with exposure to different risk factors and country of implementation. Also, birth asphyxia as a risk condition has not been well studied. To address these limitations, we conducted a randomized controlled trial to test the hypothesis that there will be differential developmental trajectories favoring those who receive EDI versus a health education intervention in children in rural areas of India, Pakistan, and Zambia. METHODS:Children with and without birth asphyxia were randomized to EDI or control intervention, which was implemented by parents who received training in biweekly home visits initiated before child age 1 month and continuing until 36 months. Development was assessed in 376 children at ages 12, 24, and 36 months using the Bayley Scales of Infant Development and Ages & Stages Questionnaire administered by evaluators blind to intervention assignment and risk condition. RESULTS: Longitudinal mixed model analysis indicated that EDI resulted in better development over 36 months in cognitive abilities, regardless of risk condition, maternal resources, child gender, or country. Psychomotor development and parent-reported general development showed similar trends as for cognitive abilities, but were not statistically different between intervention conditions. Developmental differences were observed first at 36 months of age. CONCLUSION: Early developmental intervention has promise for improving development in children across developing countries when exposed to various risk conditions. EDI should be one prominent approach used to begin to address long-term outcomes and intergenerational transmission of poverty.
Authors: Susan P Walker; Theodore D Wachs; Julie Meeks Gardner; Betsy Lozoff; Gail A Wasserman; Ernesto Pollitt; Julie A Carter Journal: Lancet Date: 2007-01-13 Impact factor: 79.321
Authors: Waldemar A Carlo; Shivaprasad S Goudar; Omrana Pasha; Elwyn Chomba; Jan L Wallander; Fred J Biasini; Elizabeth M McClure; Vanessa Thorsten; Hrishikesh Chakraborty; Dennis Wallace; Darlene L Shearer; Linda L Wright Journal: J Pediatr Date: 2012-11-16 Impact factor: 4.406
Authors: Waldemar A Carlo; Shivaprasad S Goudar; Imtiaz Jehan; Elwyn Chomba; Antoinette Tshefu; Ana Garces; Sailajanandan Parida; Fernando Althabe; Elizabeth M McClure; Richard J Derman; Robert L Goldenberg; Carl Bose; Nancy F Krebs; Pinaki Panigrahi; Pierre Buekens; Hrishikesh Chakraborty; Tyler D Hartwell; Linda L Wright Journal: N Engl J Med Date: 2010-02-18 Impact factor: 91.245
Authors: Jan L Wallander; Elizabeth McClure; Fred Biasini; Shivaprasad S Goudar; Omrana Pasha; Elwyn Chomba; Darlene Shearer; Linda Wright; Vanessa Thorsten; Hrishikesh Chakraborty; Sangappa M Dhaded; Niranjana S Mahantshetti; Roopa M Bellad; Zahid Abbasi; Waldemar Carlo Journal: BMC Pediatr Date: 2010-04-30 Impact factor: 2.125
Authors: Sophie H Eickmann; Ana C V Lima; Miriam Q Guerra; Marilia C Lima; Pedro I C Lira; Sharon R A Huttly; Ann Ashworth Journal: Dev Med Child Neurol Date: 2003-08 Impact factor: 5.449
Authors: Sally Grantham-McGregor; Yin Bun Cheung; Santiago Cueto; Paul Glewwe; Linda Richter; Barbara Strupp Journal: Lancet Date: 2007-01-06 Impact factor: 79.321
Authors: Abigail L H Kroening; Jessica A Moore; Therese R Welch; Jill S Halterman; Susan L Hyman Journal: Pediatrics Date: 2016-08-15 Impact factor: 7.124
Authors: Jan L Wallander; Fred J Biasini; Vanessa Thorsten; Sangappa M Dhaded; Desiree M de Jong; Elwyn Chomba; Omrana Pasha; Shivaprasad Goudar; Dennis Wallace; Hrishikesh Chakraborty; Linda L Wright; Elizabeth McClure; Waldemar A Carlo Journal: BMC Pediatr Date: 2014-10-25 Impact factor: 2.125
Authors: Catherine M Kirk; Jean Claude Uwamungu; Kim Wilson; Bethany L Hedt-Gauthier; Neo Tapela; Peter Niyigena; Christian Rusangwa; Merab Nyishime; Evrard Nahimana; Fulgence Nkikabahizi; Christine Mutaganzwa; Eric Ngabireyimana; Francis Mutabazi; Hema Magge Journal: BMC Pediatr Date: 2017-11-15 Impact factor: 2.125
Authors: Eric Ngabireyimana; Christine Mutaganzwa; Catherine M Kirk; Ann C Miller; Kim Wilson; Evodia Dushimimana; Olivier Bigirumwami; Evelyne S Mukakabano; Fulgence Nkikabahizi; Hema Magge Journal: Matern Health Neonatol Perinatol Date: 2017-07-12